Spider plot showing the best response as per RECIST 1.1 criteria and duration of response as per histological subtype.
anaemia, neutropenia
ANAEMIA, ADVERSE EVENT, MYASTHENIA GRAVIS, NEUTROPENIA
Cohort 1 with niraparib monotherapy (Adverse events that were considered related to therapy were mostly grade 1–2. Related grade ≥3 AEs occurring in ≥ 10% of women were anaemia (27%) and neutropenia (14%). One patient experienced an AE of special interest, grade 3 myasthenia gravis. Any AE occurring in ≥15% of women is shown on Table 